Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lexicon Pharmaceutcl (LXRX)

Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lexicon Pharmaceutcl 2445 TECHNOLOGY FOREST BLVD SUITE 1100 THE WOODLANDS TX 77381 USA

www.lexpharma.com Employees: 285 P: 281-863-3000 F: 281-863-8088

Description:

Lexicon Genetics Incorporated is a leader in defining the functions of genes for drug discovery using large-scale knockout mouse technology. Lexicon has invented high-throughput gene trapping technology to discover thousands of genes and expand its OmniBank library of tens of thousands of mouse clones. The Company uses an integrated platform of functional genomictechnologies to accelerate large-scale analysis of mammalian gene function for drug discovery.

Key Statistics

Overview:

Market Capitalization, $K 300,409
Enterprise Value, $K 377,449
Shares Outstanding, K 246,237
Annual Sales, $ 1,200 K
Annual Net Income, $ -177,120 K
Last Quarter Sales, $ 1,650 K
Last Quarter Net Income, $ -53,430 K
EBIT, $ -197,050 K
EBITDA, $ -194,720 K
60-Month Beta 1.24
% of Insider Shareholders 6.80%
% of Institutional Shareholders 74.70%
Float, K 229,493
% Float 93.20%
Short Volume Ratio 0.59

Growth:

1-Year Return -18.58%
3-Year Return -74.79%
5-Year Return -65.34%
5-Year Revenue Growth -98.10%
5-Year Earnings Growth 30.70%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.17 on 08/01/24
Next Earnings Date 11/13/24
Earnings Per Share ttm -0.78
EPS Growth vs. Prev Qtr 15.00%
EPS Growth vs. Prev Year 22.73%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-7 on 05/21/15

LXRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -105.38%
Return-on-Assets % -61.89%
Profit Margin % -14,760.00%
Debt/Equity 0.41
Price/Sales 398.81
Price/Cash Flow N/A
Price/Book 2.00
Book Value/Share 0.97
Interest Coverage -12.52
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar